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ABSTRACT 
Optimization and characterization of the Bulk FDA viability assay to quantify living 
planktonic biomass 
 
by 
Brian N. Maurer 
Master of Science in Marine Science 
California State University Monterey Bay, 2013 
 
 The detection and quantification of viable aquatic biomass, especially of the 
microbial community, is a fundamental aspect of ecological, oceanographic, 
environmental and other specialized fields.  The abundance and activity of aquatic 
microbial communities and how they change in space, time or in response to some 
environmental perturbation are subjects of significant research interest.  Environmental 
management officials and technicians must quantify viable marine microorganisms in 
waste, gray, drinking and ballast water to determine if regulations are met.  
Unfortunately, few methods exist to assess viable biomass; those that do are often 
laborious, unreliable, expensive, qualitative rather than quantitative, or restricted to the 
measurement of a specific group of organisms.  Moreover, the distinction between living 
and dead can be ambiguous for marine microorganisms, whether this distinction is made 
visually or via an indirect process, such as a chemical indicator.  A need exists in 
scientific and public sectors to develop a convenient means to quantify the total, or bulk, 
viable biomass present in any water sample.  A method for determination of total living 
biomass based on bulk fluorometric detection in simple optical reaction cuvettes has 
recently been developed (Welschmeyer and Maurer, 2013); the method, termed the Bulk 
FDA technique, is based on quantitative conversion of fluorescein diacetate (FDA) to the 
fluorescent product, fluorescein, by ubiquitous enzymes in living organisms.  This thesis 
describes the optimization and characterization of the Bulk FDA technique.  The 
optimized assay should prove useful in a wide range of academic and regulatory 
applications.  
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INTRODUCTION 
The Invasive Species Problem 
Aquatic invasive species are a significant threat to the well-being of global 
ecosystems.  Aquatic invasive species are organisms and plants which are introduced into 
new environments.  Once introduced, non-native species can become established, 
threatening the well-being of native ecosystems and the resources within them.  Invasive 
species can out-compete native organisms for resources or habitat, resulting in the decline 
or elimination of native species.  The majority of invasions result from the transport of 
organisms from one place to another by human activity, and the most significant transport 
mechanism, or vector, contributing to aquatic biological invasions is the uptake, transport 
and subsequent dumping of ballast water by shipping vessels (Ruiz et al., 1997), although 
it is now recognized that hull-fouling represents a significant source of invasions as well 
(Drake et al., 2007).  Presently, the rate and impact of biological invasions is increasing; 
as a result, increasing attention is being given towards the management of aquatic 
biological invasions (Ruiz and Carlton, 2002).   
The International Maritime Organization, United States Coast Guard, and other 
international agencies have recently imposed regulations requiring sterilization of water 
to be de-ballasted.  These regulations provide specific and quite stringent requirements 
regarding the numeric concentration of viable organisms permitted in three distinct size 
classes (<10µm, 10-50µm, >50µm).  Methodology does not currently exist which is 
sensitive, reliable and efficient enough to routinely evaluate ballast water treatment 
system performance at the low living biomass levels required by regulations.  This 
research sought to improve the existing Bulk FDA technique, making it sensitive, reliable 
and efficient such that is a useful tool for evaluating ballast water treatment system 
efficacy, as well as other oceanographic parameters.    
The Quantification of Viable Biomass 
The measurement of viable aquatic biomass is often required in ecological 
research to provide insight into transfer and cycling of energy and materials through the 
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microbial community, including zooplankton, phytoplankton, bacteria and viruses.  The 
size distribution of living particles in aquatic environments is a subject of longstanding 
research interest (Sheldon et al., 1972) ; measurements of bulk viable biomass among 
discrete size ranges can provide insight on this topic (Rinaldo et al., 2002).  Estimates of 
viable biomass are often more relevant than live cell concentration in ecological research 
(Holm-Hansen 1970), as metabolic activity, and therefore the effect that a group of 
organisms will have on their environment, scales with biomass rather than numeric 
concentration.  Measurements of viable biomass can also assist in investigating the 
distribution and abundance of viable organisms in space or time, such as the response of a 
microbial community to environmental perturbation (Steward et al., 1996).  Recently, the 
measurement of viable biomass has become necessary to evaluate the performance of 
ballast water treatment systems.   
 
Current Methods to Measure Viable Biomass 
A variety of methods currently exist to measure viable aquatic biomass, each with 
its own advantages and disadvantages.   
ADENOSINE 5’TRIPHOSPHATE (ATP) 
Microbial biomass can be estimated by the extraction and measurement of 
adenosine 5’triphosphate (ATP), the energy currency for living cells.  Numerous 
publications have investigated the relationship between ATP and living biomass in 
aquatic environments over the past 40 years (Hamilton and Holm-Hansen 1967, Karl 
1993).  The extraction of ATP is relatively simple in a laboratory setting, requiring cells 
to be concentrated and boiled in aqueous buffer (Tris) for a short time, then frozen until 
analysis.  The quantitative determination of extracted ATP is problematic, especially in 
the field, as it depends on the activity of a rapidly degrading enzyme, luciferase, and 
requires specialized instrumentation (luminometer) and at least 1 empirical calibration 
each time samples are run.  The ATP assay is prone to the "filtration effect" (Karl and 
Holm-Hansen 1978), in which desiccation immediately after filtration results in a rapid 
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degradation of cellular ATP.  Also, because of the ubiquitous nature of ATP, the assay is 
prone to contamination.   
CHLOROPHYLL A 
All oxygenic phytoplankton contain chlorophyll a (chl a), the primary pigment 
involved in photosynthesis.  Because chlorophyll a is fluorescent, it can be quantified by 
spectrofluorometry, either extracted in an organic solvent for the most precise 
measurement, or with field in situ or portable fluorometers. Chl a concentration per unit 
phytoplankton biomass is relatively constant.  Chl a is not, however, a reliable indicator 
of viable algal biomass, as it remains intact and fluorescent in dead cells for extended 
periods of time.  Also, because chl a is only present photosynthetic organisms, 
heterotrophic biomass must be quantified by some other means. 
PHOTOSYNTHETIC 
14
C INCORPORATION   
The photosynthetic activity of phytoplankton can be quantified by measuring the 
incorporation of inorganic 
14
C labeled bicarbonate into phytoplankton biomass after an 
incubation period.  Viable phytoplankton will fix the dissolved radioactive inorganic 
carbon into their tissue as particulate organic carbon through photosynthesis; dead cells 
will not fix radioactive carbon.  The rate of 
14
C incorporation can be used to estimate the 
quantity and/or activity of photosynthetic organisms, but does not measure heterotrophic 
growth.      
PULSE AMPLITUDE MODULATED (PAM) FLUOROMETRY 
PAM fluorometry is used to measure variable fluorescence, an indicator of algal 
cell physiological health.  Variable fluorescence indicates the presence of algal cells that 
are capable of using incident light for photosynthesis, as well as other processes.  High 
levels of variable fluorescence indicates healthy, viable cells.  While both the 
14
C and 
PAM techniques detect the presence of viable algal cells, neither is ideal for estimating 
numeric abundance of viable algal cells and both are limited to the detection of 
autotrophic cells.       
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MICROSCOPE COUNTS 
Regulations governing treated water are commonly written in the units of numeric 
concentration of living cells allowed in distinct size classes, making numeric 
quantification of living cells necessary.  One of the most commonly applied techniques to 
quantify the numeric concentration of live organisms is by direct microscopic count.  
Large and motile organisms, such as zooplankton, can be counted microscopically using 
the “poke and probe” technique to determine if organisms are alive or dead.  An organism 
displaying organ activity or motion on its own or in response to a "poke" is presumed 
alive, while an organism that does not respond when probed is presumed dead.  This 
technique cannot, however, make the distinction between live and dead for organisms 
which are non-motile, such as many phytoplankton species.  In order to make a direct live 
count of non-motile organisms, a marker or stain that distinguishes live and dead cells 
must be used.  Many viability markers are commercially available, most of which are 
colorless molecules that become fluorescent and detectable in response to an indicator of 
viability, such as enzyme activity (fluorescein diacetate (FDA), cmFDA, calcein AM).  
Other stains are used to identify dead cells, such as Sytox Green, a DNA stain that marks 
cells with compromised plasma membranes.  Analysis using these stains and markers is 
often challenging.  Viability markers, especially FDA, leak out of cells over time and the 
amount of leakage varies by cell type.  This leakage creates a time constraint on sample 
analysis. Variable fluorescence levels as fluorescein leaks can make the distinction 
between live and dead cells ambiguous.  False positives can be a problem with 
fluorogenic viability indicators, such as actively swimming dinoflagellates tagged as 
"dead" by Sytox green (Prince et al., 2008).  Microscopic direct count techniques are 
tedious, prone to user error and statistically challenged due to the low volumes of sample 
analyzed.  
FLOW CYTOMETRIC COUNTS 
Flow cytometry functions by focusing particles and/or cells into a single file 
stream and measuring the fluorescence and scattering characteristics of individual 
particles.  Live cells can be enumerated by employing the same stains and markers as 
used in epifluorescence microscopy; an increase in intracellular fluorescence indicative of 
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metabolic activity or the presence of DNA is readily detected by the instrument.  Flow 
cytometry counts improve upon epifluorescent counts by eliminating the human 
interpretation of fluorescence and size.  However, the same issues of marker leakage, 
false positives and low analysis volumes that plague microscope count techniques are 
present in flow cytometric analysis.  Flow cytometric analysis is also restricted to cells 
<70 micron, as the aperture is easily clogged by large particles.           
GROW OUT TECHNIQUES 
Grow out methods are among the most trusted and commonly used methods to 
quantify or identify the presence of live organisms; a sample that exhibits growth clearly 
possesses live cells or organisms.  Live bacteria and phytoplankton can be quantified by 
Most Probable Number (MPN) methods in which serial dilutions of sample water are 
made in many replicates and scored for growth after an incubation period.  The change in 
bulk Chl a fluorescence over time provides the assessment of algal cell growth, while 
colony formation indicates bacterial growth.  An algorithm calculates the most probable 
initial concentration of live cells based on the number of replicates showing growth at 
each dilution.  Heterotrophic plate counts (HPC) are used to quantify cultivable bacteria; 
sample water is spread in a thin layer on agar plates and scored for colony formation after 
an incubation period.  Unfortunately, most aquatic microorganisms from natural samples 
do not grow well in a laboratory setting (Staley and Konopka 1985, Connon and 
Giovannoni 2002).  It is estimated that only 1% of marine bacteria, for example, are 
cultivated with the HPC technique (Wagner et al., 1993).  Thus, grow-out techniques are 
poorly-suited for quantitative determination of live cell concentration; estimates of live 
cell concentration by grow-out techniques are inherently conservative.              
Esterases and Fluorescein diacetate 
Esterases are cytoplasmic enzymes that are present in all domains of life (Rotman 
and Papermaster, 1966) and function by hydrolyzing esters into alcohol and acid 
constituents.  There are many different types of esterases that function in a wide range of 
biological processes.  These include lipases, which cleave lipids, and 
acetylchloinesterases, which hydrolyze the neurotransmitter acetylcholine.  In algal cells, 
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esterases are essential for the turnover of phospholipids in membranes, which is 
correlated with metabolic activity  (Dorsey et al., 1989). Measurements of esterase 
activity (EA) can be used to assess if an organism, or group of organisms, is alive or dead 
(Steward et al., 1999).  Esterases are present in all marine organisms, and are only present 
in live or recently deceased organisms.  As such, they make an excellent proxy for bulk 
viable biomass.             
Fluorescein diacetate (FDA) has been routinely applied to assess cell-specific 
metabolism and viability in single and multi-cellular organisms (Green et al., 2006).  
FDA was introduced almost 50 years ago as a chromogenic viable cell marker (Rotman 
and Papermaster, 1966), making it one of the oldest viability detection methods in use 
today.  FDA is a non-fluorescent, non-polar, esterified compound that freely enters both 
live and dead cells.  Inside a metabolically active cell, FDA is hydrolyzed by cytoplasmic 
esterases, lipases and proteases, which remove the 2 acetate groups and produce the green 
fluorescent, polar compound fluorescein.  The rate of fluorescein production by a cell 
reflects its cumulative EA.  The polar nature of fluorescein causes it to initially 
accumulate inside cells, enabling the detection of bright green fluorescent viable 
organisms by epifluorescence microscopy or flow cytometry.  However, over time, 
fluorescein will leak out of cells and into the extracellular medium (Rotman and 
Papermaster, 1966, Jochem, 1999).   
The green fluorescent molecule fluorescein was first prepared  by Adolf von 
Baeyer in 1871 by fusing a mixture of pthalic anhydride and resorcinol.  In 1927, 
fluorescein diacetate (FDA), a colorless derivative of fluorescein, was created by 
Orndorff and Hemmer.  In 1966, Rotman and Papermaster used FDA to describe the 
pattern and kinetics of intracellular fluorescein accumulation and leakage in cultured 
mammalian cells, showing that intracellular fluorescein accumulation occurs only in 
viable cells with intact cell membranes.  The vast majority of studies involving FDA have 
used the marker to indicate cell-specific viability, however, several efforts have been 
made to use FDA as a bulk indicator of living biomass. Swisher and Carroll (1980) 
demonstrated that FDA hydrolysis correlated with cumulative biomass of fungi, bacteria 
and algae growing on Douglas fir foliage.  Schnurer et al. (1982) developed a protocol 
using FDA to measure the activity of microbes in soil and litter, and found that FDA 
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hydrolysis rates increased linearly with the addition of soil and bacteria cultures, and was 
correlated with respiration rates in soils.  These efforts to measure bulk viable biomass 
with FDA were complicated by high non-biological fluorescein production in the 
incubation solutions without live cells (Clarke et al., 2001), resulting in large "blanks" 
and associated decreases in sensitivity.  Because the density of living biomass is quite 
high in environments such as soils, these bulk assays involving FDA are useful despite 
significant non-biological fluorescein production.  Aquatic environments, in contrast, 
typically show much lower density of living organisms.  High non-biological fluorescein 
production in the incubation solutions renders these assays too insensitive to be useful in 
aquatic environments.       
The Bulk FDA technique 
The Bulk FDA technique, which takes advantage of fluorescein leakage to 
achieve a bulk indication of esterase activity from a heterogeneous ballast water sample, 
was first described for ballast water work by Welschmeyer and Maurer (2011).  Recently, 
the method has been described for general use in determination of living biomass for a 
broad spectrum of microbial research areas (Welschmeyer and Maurer, 2013); this 
publication presents the fundamental aspects of the technique in detail.  Some of the data 
presented therein are summarized below to provide the starting point for the optimization 
process.   
CHARACTERIZATION OF FLUORESCEIN LEAKAGE 
Intracellular fluorescein accumulation and subsequent leakage out of cells which 
occur during an incubation with FDA was characterized quantitatively using several algal 
cultures.  The general pattern was essentially the same for all cell types tested, varying in 
the quantity of fluorescein accumulated and leaked and the duration of each phase 
(Figure 1).  Upon addition of FDA, intracellular fluorescence rises rapidly to some 
maximum level, then begins to decrease as fluorescein leaks out of cells.  The cumulative 
leakage of all cells being assayed results in a linear increase of extracellular fluorescein 
concentration over time.  Extracellular fluorescein production (FP) forms the basis of the 
Bulk FDA technique.   
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FLUORESCEIN PRODUCTION IS PROPORTIONAL TO LIVING BIOMASS 
The relationship between FP and biomass filtered was demonstrated by 
quantitatively filtering a range of volumes of algal cultures and size fractionated natural 
samples onto GF/F and 10µm nylon filters, creating gradients of biomass loaded, and 
carrying out incubations with FDA.  Linear relationships were observed between biomass  
 
Figure 1: The pattern of intracellular fluorescein accumulation and leakage during 
an incubation with FDA and the pattern of extracellular fluorescein production (FP) 
during the same incubation 
 
and FP, confirming that the Bulk FDA assay responds proportionally to biomass 
filtered (Figure 2). 
Cultured Dunaliella sp.  cells treated with a variety of known kill factors show 
reduced or eliminated FP relative to untreated controls (Figure 3) (all control values were 
normalized to 1).  Ballast water samples were collected aboard the T.S. Golden Bear in 
Kobe, Japan, Guam and Saipan in June 2010 and in San Francisco Bay in December, 
2010; uptake, control and treatment (electrolytic chlorination) ballast water samples were 
size fractionated and tested with the Bulk FDA technique (Figure 4).  Treated samples 
  
9 
show significant reduction of FP in all size classes; corroborative assays showed a similar 
treatment effect.  Size fractionated Bulk FDA data also show the expected trend of 
biomass distribution among size classes: approximately 70% of the total biomass in 
uptake samples was present in the smallest size fraction (0.7-10 µm). 
 
 
Figure 2: Bulk FDA response to biomass gradients, size fractionated Moss Landing 
harbor water and Thalassiosira sp. culture 
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Figure 3: Normalized Bulk FDA response to kill treatments (Dunaliella sp.) 
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Figure 4: Size-fractionated Bulk FDA response to electrolytic chlorinating ballast 
water treatment system (BWTS)  
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THE RELATIVE PROPORTION OF INTRACELLULAR AND EXTRACELLULAR 
FLUORESCENCE 
The Bulk FDA assay depends upon the measurement of fluorescein in the 
extracellular fluid.  The relative proportion of extracellular and intracellular fluorescein 
that combine to make up total fluorescein was quantified.  Equivalent numbers of 
cultured Tetraselmis sp. cells were incubated in the presence of FDA for 1-hour in 
replicates.  Some replicates were measured without removing cells, thus making a 
measurement of total fluorescein (intracellular + extracellular).  Other replicates were 
measured after removing the cells by filtration, thus removing the intracellular fraction of 
total fluorescein.  On average, extracellular fluorescein makes up 97% of total 
fluorescein; individual values ranged from 94-99% extracellular fluorescein.  Because the 
majority of fluorescein produced by live cells has leaked out of cells by the end of a 1-
hour incubation, cells can be removed prior to making the fluorescence measurement 
while retaining the majority of the fluorescent signal. 
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THESIS GOALS 
The goals of the current thesis are as follows:    
1) Optimize the Bulk FDA technique.  
2) Characterize the Bulk FDA technique, including field verification and 
correlation with other established indicators of living biomass.   
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METHODS 
The Bulk FDA technique 
Experiments were preformed over the course of the optimization process; many of 
the experiments presented are testing aspects of the protocol itself.  Therefore, the 
protocol for the Bulk FDA assay is not identical for all data presented.  Moreover, the 
Bulk FDA technique can be performed in several ways.  If more signal is desired, the 
temperature can be increased or the incubation can run for longer times.  Acetone can be 
added at 1:1 concentration to terminate the reaction if a fluorometer is not available.  The 
final optimized technique is described below.  Experiments were carried out according to 
the following technique, unless otherwise stated. 
REAGENTS  
Fluorescein diacetate (Sigma-aldrich, part # F7378 MW 416.38): 2.5 mM FDA in 
DMSO (1.04 mg/mL).   
Reagent A: 500mM d-Sorbitol + 20mM MES-KOH pH 6.5 
 d-Sorbitol (Fisher), Part # S459-500, C6H14O6, MW=182.17 g/mol  
 500mM MES hydrate (ACROS Organics), Part # 172590250, 
MW=195.23 g/mol 
 Potassium hydroxide pellets (85%, ACROS organics, part #206075000, 
MW 56.11) 
500 mM d-Sorbitol and 500 mM MES were prepared in ultrapure water.  Using a 
calibrated pH meter, KOH pellets were added to the MES solution until the solution 
reached pH 6.5.  1 part 500 mM MES-KOH pH 6.5 was added to 24 parts 500 mM d-
Sorbitol.  The resulting solution was transferred to an autoclave-safe container, the bottle 
caps were tightened one quarter turn and autoclaved 20 minutes on liquid setting.  After 
autoclaving, the solution was allowed to cool before using. 
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PROTOCOL 
2.5mL sterilized Reagent A was dispensed into disposable plastic cuvettes.  
Biomass was collected on filters of the desired pore size by gravity or vacuum filtration; 
nylon and GF/F filters were used for all experiments presented here.  Immediately after 
filtration, the filter was placed into the cuvette using forceps, 4µl FDA was added (final 
concentration 10µM FDA), the sample was inverted to mix and incubated in the dark at 
20ºC for 1 hour.  At least 1 blank was included with each experiment.  The blank should 
mimic the samples optically and chemically, but without viable organisms.  Such a blank 
was prepared by treating sample water with 60ppm sodium hypochlorite and incubating 
for at least 30 minutes to kill all organisms before processing for Bulk FDA.  If a more 
simple operation was desired, a "buffer only" blank was used in which FDA is added to 
incubation buffer alone.  The bleach "killed" blank and "buffer only" blank generate 
similar fluorescence values.  After a 1-hour incubation, the filter was removed using 
forceps.  If GF/F filters were used, the filter was pressed against the side of the cuvette to 
squeeze fluid out of the filter, then the sample was centrifuged 30 seconds at 13,000 rpm 
to remove the pulp left behind by the GF/F filter.  The fluorescence measurement was 
made (490 nm excitation, 513 nm emission) immediately after spinning down (or after 
removing the filter for nylon filters).  A SPEX Fluoromax-2 spectrofluorometer and 
Turner Designs Aquafluor handheld spectrofluorometer were used for all measurements 
presented here.  
Culture maintenance 
Marine algal cultures used for the optimization experiments were reared at 25°C 
under natural light in 0.45 µm filtered seawater (FSW) with Guillard's marine enrichment 
solution added at F/2 concentration (50-fold dilution of stock solution).  A complete 
listing of the cultured species is provided by Table 1.  Experiments determining the 
relationship between biovolume, ATP and Bulk FDA using marine cultures were 
conducted using cells grown in FSW plus F/8 Guillard's (200-fold dilution of stock 
solution).  F/8 concentration was used (rather than F/2) to prevent the precipitation of 
silicic acid.  Freshwater cultures were grown under the same conditions in AlgaGro 
freshwater media (1x concentration, pH 7.8).  Media was autoclaved 20 minutes in glass 
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culture flasks with cotton stoppers.  Inocula were made into room temperature media by 
either pouring or pipeting.  Algal cultures were collected from the MLML Biological 
Oceanography culture stock, Carolina Biological Supply, and the National Center for 
Marine Algae and Microbiotia (NCMA).  
 
Table 1:  Taxonomic listing of freshwater and marine algal cultures used in 
optimization experiments and to determine the relationship between fluorescein 
production, ATP and cell volume 
Phylum Class Genus Species 
Heteroknotophyta Coscinodiscophyceae Thalassiosira Pseudonana 
Heteroknotophyta Bacillariophyceae Phaeodactylum Tricornutum 
Heteroknotophyta Bacillariophyceae Nitzschia sp. 
Haptophyta Prymnesiophyceae Pleurochrysis Carterae 
Chlorophyta Chlorophyceae Tetraselmis sp. 
Chlorophyta Chlorophyceae Dunaliella sp. 
Cyanobacteria Synechococcophycideae Synechococcus sp. 
Chlorophyta Zygnemophyceae Staurastrum sp. 
Chlorophyta Zygnemophyceae Cosmarium sp. 
Heteroknotophyta Coscinodiscophyceae Odontella Mobiliensis 
Heteroknotophyta Coscinodiscophyceae Coscinodiscus sp. 
Heteroknotophyta Coscinodiscophyceae Helicotheca Tamensis 
Heteroknotophyta Coscinodiscophyceae Helicotheca Tamensis 
Chlorophyta Trebouxiophyceae Chlorella sp. 
Chlorophyta Chlorophyceae Haematococcus sp. 
Heteroknotophyta Coscinodiscophyceae Thalassiosira Weissflogii 
 
Environmental Sample Collection 
Natural water samples were collected around Moss Landing and southern 
Monterey Bay and used for optimization experiments, as well as for correlation with ATP 
and other live cell indicators.  In most cases, seawater was sampled in polypropylene 
bottles or carboys at the surface in convenient locations, such as the MLML small boats 
dock.  Offshore Monterey Bay samples were collected throughout the water column by 
deep-water CTD casts aboard the Research Vessel Point Sur March 28-29th, 2012, which 
were used for comparisons between fluorescein production and ATP concentration.   
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Flow cytometry 
Flow cytometry was used often throughout the research presented here.  A BD 
FACScan flow cytometer was used for experiments characterizing the intracellular 
pattern of fluorescein accumulation and leakage during incubation with FDA; these files 
were analyzed using Winmidi software.  An Accuri C6 flow cytometer was used for all 
other experiments, usually to count live cells of natural samples and algal cultures; data 
analysis for these files was completed in the Accuri software package.  High intracellular 
green fluorescence (detector FL1) after a 10 minute incubation with 10 µM FDA marks 
cells as alive.  If a cell has a FL1 score higher than the set threshold value for a given size 
range of cells (>10
5
 FL1 for cells 10-50 µm), it is scored as live.  This threshold value 
was determined empirically using hypochlorite treated samples as negative controls, and 
untreated samples as positive controls.  The number of live cells divided by the analysis 
volume yields live cell concentration.  Measuring the live cell concentration enables one 
to load a known quantity of cells for a Bulk FDA experiment.  Cultures of the small algal 
cells were counted by flow cytometry to determine cell concentration, while cultures of 
large cell size were counted by epifluorescence microscopy.   
Epifluorescence microscopy 
Numeric cell concentration of large-sized algal cultures could not be measured by 
flow cytometry, as large particles will clog the instrument.  Therefore, in order to count 
large cells, 1-10 mL of the large-sized cultures were filtered onto 0.2 µm polycarbonate 
filters, placed on microscope slides and counted by epifluorescent microscopy.  At least 3 
slides were prepared for each culture and a minimum of 100 cells were counted per slide.  
A fraction of the filter area was counted; this count was extrapolated to the entire 
filtration area to calculate cell concentration.        
Cell volume measurements: Coulter Counter 
The cell volume of algal cultures was measured using a Z2 Beckman Coulter 
Counter.  Marine cultures were diluted in FSW until an acceptable cell density was 
achieved (saturation indicator 0.3-.07).  Freshwater cultures were diluted in AlgaGro 
freshwater media and 20% FSW was added to maintain a saline sample solution.  20% 
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FSW was shown to be the optimal salinity for both preserving the freshwater cell 
structure and maintaining the conductive solution that the Coulter Counter requires for 
signal transmission.  The mean cell size, given as equivalent spherical diameter (ESD), 
was used rather than mode or median.  A minimum of three samples were run for each 
culture, the average ESD of these three runs was used to calculate cell volume. 
ATP 
ATP was measured in tandem with fluorescein production (FP) from both natural 
samples collected in Monterey Bay and algal cultures.  Biomass was collected by filtering 
sample water quantitatively onto GF/F or larger pore size nylon filters, just as in the Bulk 
FDA assay.  Immediately after filtration, ATP was extracted by placing the filters into 13 
mm diameter borosilicate test tubes containing 4 mL of boiling 20 mM Tris Buffer, pH 
7.75.  The filters were boiled at 100 ºC for 5 minutes, allowed to cool and then stored at -
20°C until analysis.   
ATP samples were analyzed using the Promega Enlighten™ ATP reagent kit.  
This kit uses a luciferin-luciferase reagent to measure ATP via the production of light 
according to the following reaction (Hamada et al. 1998): 
 
This light, termed luminescence, is proportional to ATP concentration.  
Luminescence was measured on a Turner Designs 20/20 ATP Luminometer.  100µL of 
the ATP extract was added to 50µL of luciferin-luciferase reagent in 3mL clear 
polystyrene uncapped tubes, mixed gently and measured on the ATP Luminometer using 
a 10-second integration time.  ATP standards are included in the kit and were prepared 
using the same ratio of analyte volume to luciferin-luciferase reagent as used for samples.  
These standards were used to create a response factor to convert luminescence readings 
to ATP concentration (Hamada et al. 1998). 
Pulse Amplitude Modulated (PAM) Fluorometry 
Pulse Amplitude Modulated (PAM) fluorometry was used to measure variable 
fluorescence of algal cells, an indicator of physiological health.  The commonly used 
ratio Fv/Fm expresses variable fluorescence (equation given below).   
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Fv/Fm ranges from 0-0.8; low values (<0.2) indicate dead or unhealthy cells, 
intermediate values indicate cells stressed to some degree, while high values (>0.5) 
indicate robust, healthy cells capable of using incident light for photosynthesis.  3mL of 
cell suspension was transferred into round glass cuvettes and placed in the dark 
measuring chamber of the PAM fluorometer.  Samples were dark adapted for at least 30 
seconds and then excited with a high dose of light, termed a saturation pulse.  Minimum 
fluorescence is measured immediately before this pulse, while maximum fluorescence is 
measured in response to this pulse.
20 
 
 
RESULTS 
Optimization Results 
The preliminary results presented above show that extracellular FP is proportional 
to bulk living biomass.  While this fundamental aspect of the assay is clear, there are 
several elements of the initial assay protocol which restrict its sensitivity, reproducibility 
and ease of use, most notably, the lack of a stable incubation buffer and non-biological 
fluorescein production.  These issues, as well as other parameters involved in the 
protocol, made logical targets for optimization. The following elements on the Bulk FDA 
assay were investigated during the optimization process: 1) pH, 2) non-biological 
fluorescein production,  3) incubation buffer, 4) temperature, 5) incubation time, 6) 
incubation volume, 7) FDA concentration 8) sample mixing.  The goal of the 
optimization process is to understand the effects of each aspect on the Bulk FDA 
technique, and to use this knowledge to improve the assay, making it as sensitive, precise, 
accurate, fast and simple as possible.  
PH EFFECT ON FLUORESCEIN FLUORESCENCE 
The intensity and wavelength of fluorescein fluorescence is very dependent on 
pH.  Fluorescein fluorescence increases as pH increases, fluorescing most intensely at 
and above pH 8 (Figure 5).  The increase in fluorescein fluorescence from pH 3.9 to pH 
8.1 is roughly 50-fold.  Fluorescein fluorescence remains constant between pH 8 and pH 
10.  Below pH 5, fluorescein fluoresces maximally when excited by 444 nm excitation 
light.  Above pH 5, fluorescein fluoresces maximally when excited by 489 nm excitation 
light.  Fluorescein fluorescence emission is at 515 nm across all pH levels.         
ABIOTIC FLUORESCEIN PRODUCTION 
One of the most important aspects of the optimization process was controlling and 
reducing the blank, the signal generated by the incubation conditions in the absence of 
live cells.  This production of fluorescein is termed “abiotic” because it is produced by 
the chemical composition of the incubation buffer, not by the enzyme activity of live  
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Figure 5: The pH dependence of fluorescein fluorescence 
 
cells.  When the Bulk FDA incubation is carried out using filtered, autoclaved 
seawater (FSW) as the incubation buffer, very high FP is observed in the cell-free blank.  
Lowering the pH of FSW with hydrochloric acid results in a large reduction of blank 
fluorescence.  Lowering the pH from 7.8 to 6.0 causes a 32-fold reduction in abiotic FP 
(Figure 6).  The fluorescence live cell samples decreases at lower pH, yet does so less 
than the blank, resulting in much improved signal/noise ratios in acidified FSW relative 
to unadjusted FSW.  Some of the reduction in the blank when using acidified FSW is due 
to the decrease in intensity of fluorescein fluorescence due to lowered pH alone.  
However, the reduction in blank fluorescence when using FSW at pH 7.8 to acidified 
FSW at pH 6.0 (32-fold) exceeds the reduction of fluorescence from sodium fluorescein 
standards observed at pH 7.8 and pH 6.0 (~2.5-fold) (Figure 5).  This suggests that the 
decreased efficiency of fluorescein fluorescence at low pH is only a partial contributor 
towards the decrease in abiotic FP in FSW pH 6.0.  The chemical composition of FSW at 
pH 7.8 hydrolyzes more FDA than at pH 6, resulting in high abiotic FP values in the 
absence of esterase enzymes.          
Acidified, filtered and autoclaved seawater is an acceptable Bulk FDA incubation 
solution for providing relative FP measurements from marine organisms.  However, the 
pH of FSW acidified with hydrochloric acid is not stable when exposed to air; the pH will  
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Figure 6: Abiotic FP resulting from bulk FDA incubations using non-acidified (pH 
8) and acidified (pH 7 and 6) FSW as the incubation buffer. 
 
rise continuously until it reaches normal seawater pH (pH 7.8), therefore, the 
actual pH during an incubation with acidified FSW cannot be predicted.  The mass of 
fluorescein produced by a sample is determined by relying on fluorescein standards of 
known pH.  If the pH is not known at the time the fluorescent measurement is made, the 
fluorescent result cannot be converted to fluorescein concentration; the actual mass of 
fluorescein produced by the cells being assayed cannot be determined.  Acidified 
seawater thus indicates relative FP and does not provide a standardized incubation 
condition, which greatly compromises reproducibility of the assay from day to day.  An 
incubation buffer that maintains constant pH is clearly needed.  
INCUBATION BUFFER OPTIMIZATION 
The ideal buffer for the Bulk FDA assay will possess the following qualities: 
1) Low abiotic fluorescein production (low blank) 
2) High and consistent fluorescein production per unit living biomass 
3) Buffered to maintain constant pH 
4) Autoclavable to maintain sterility during storage 
5) Compatible with freshwater and marine organisms 
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Many potential incubation solutions, often containing supplementary reagents, 
were tested during the optimization process; many of the experiments involving 
unsuccessful incubation buffers are not presented here.  While the selection of test 
solutions was guided by all the criteria listed above; final selection was based on the 
signal to noise ratio, given by criteria 1 and 2, so as to provide the best sensitivity for 
detection of low viable biomass ranges.  Commonly used buffered solutions, such as 
phosphate, citric acid and tris based buffers, were tested at many concentrations and pH 
levels.  Artificial seawater solutions were tested.  Supplemental reagents, including DTT 
and EDTA, were tested as additives to the buffers in attempts to help facilitate enzymatic 
activity.  Reagents designed to permeabilize cell membranes and enhance leakage were 
tested, such as detergents (Triton X-100) and lysozyme extracts.  None of the 
supplementary reagents tested improved the assay; most led to a drastic reduction in FP.  
Only one of these solutions, d-sorbitol, represented an improvement over acidified FSW 
at satisfying the optimization criteria.         
d-Sorbitol is identified by Welschmeyer and Maurer (in prep, 2013) as a 
promising Bulk FDA incubation solution.  d-Sorbitol, also called Glucitol, a sugar 
alcohol often used as a sugar substitute in food items, can serve as an osmoproctectant in 
the culturing of algae.  Experiments confirm that 500mM sorbitol gives a larger signal 
and lower abiotic FP than acidified FSW when Bulk FDA incubations are carried out 
with fixed quantities of both freshwater and marine algal cultures, as well as natural 
samples (Figure 7a), resulting in higher signal/noise ratios in 500mM sorbitol relative to 
acidified FSW (Figure 7b and 7c).  The signal/noise ratio improves most drastically, as 
much as 6-fold, when a small quantity of cells are loaded, suggesting that sorbitol is a 
more effective incubation solution than acidified FSW for detecting low biomass levels.  
Sorbitol is not, however, buffered to maintain constant pH.     
BUFFERING THE INCUBATION SOLUTION 
The pH of 500mM sorbitol, when it is not adjusted or buffered, varies between 
3.7 and 5.4.  Freshly prepared sorbitol is pH 5.4; the pH will typically decrease over time.  
The pH of sorbitol will change drastically if more basic substances are added, such as 
seawater (Figure 9).  Because a small, and likely variable, volume of seawater is retained  
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Figure 7: Experiments comparing the use of acidified FSW vs. 500mM sorbitol as 
bulk FDA incubation buffers 
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on filters used to collect cells, the incubation solution must be buffered against pH 
changes caused by seawater retained on the filter.  For example, GF/F filters retain 
approximately 100µL of fluid after vacuum filtration.  The optimal buffering agent must 
efficiently stabilize the pH of sorbitol, but it must also create a solution that is optimal in 
regard to maximizing signal/noise ratio and the other criteria listed above.    
The buffers MES, MOPS and HEPES were tested in sorbitol at several 
concentrations and pH levels.  The signal to noise ratio in each buffered solution was 
used as the primary criteria for selecting the optimal buffering agent.  10,000 Tetraselmis 
sp. cells were filtered onto GF/F filters and incubated in each solution with 10µM FDA.  
The blank consisted of a GF/F prepared the same way as above, but with autoclaved FSW 
substituted for the algal culture.  FP from the Tetraselmis sp. samples divided by FP from 
the blank yields the signal/noise ratio.  500mM sorbitol stabilized with MES-KOH pH 6 
gave a lower blank and a higher signal to noise ratio than solutions buffered with HEPES 
or MOPS (Figure 8).   
The buffering capacity of the buffers MES, HEPES and un-buffered Sorbitol was 
determined by titrating filtered seawater (pH 7.9) into the solution and monitoring the 
resulting pH.  Filtered seawater was used to mimic the pH perturbation expected during 
an incubation.  500mM sorbitol with 2 mM MES-KOH pH 6 changed less in response to 
the addition of filtered seawater than 2mM HEPES pH 6 and unbuffered sorbitol (Figure 
9).   
 500mM sorbitol with MES-KOH pH 6 showed the greatest buffering capacity 
while yielding the lowest blank and highest signal to noise ratio of the buffers tested 
above.  The next step in the optimization process was determining the ideal concentration 
of MES-KOH.  Experiments were set-up to answer which MES-KOH pH 6 concentration 
would give the highest signal to noise ratio, lowest blank, and would buffer most 
effectively.  Experiments comparing 2, 10, and 50 mM MES-KOH pH 6 in 500mM 
sorbitol showed roughly equivalent signal to noise ratios.  Titrating all three buffers with 
bleach (which raises pH) showed that the buffering capacity of the solution varied as a 
function of the MES concentration; low concentrations of MES produced a weakly 
buffered solution, while raising the concentration of MES to 20 mM resulted in a solution  
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Figure 8: The signal/noise ratios resulting from bulk FDA incubations in 500mM 
sorbitol buffered with 2mM, pH 6 MES, MOPS and HEPES 
 
Figure 9: The buffering capacity of 500mM sorbitol in response to FSW without a 
buffering agent, buffered with 2mM MES and with 2mM HEPES 
 
resistant to pH change.  Based on these results, the optimal MES concentration 
was determined to be 20 mM.   
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 In the experiments presented above, 500mM sorbitol + 20mM MES pH 6.0 gave 
higher signal/noise ratio and buffering capacity than lower pH levels. Subsequent 
experiments were performed to determine the optimal buffer pH by preparing 500mM 
sorbitol with 20mM MES adjusted with KOH to  pH 5-7.8.  In one instance, pH 6.0 gave 
a 1.4-fold higher signal/noise ratio than pH 6.5 using cultured Tetraselmis sp. cells (9µm 
ESD) (Figure 10a) collected on GF/F filters.  However, repeating this experiment under 
the same conditions showed that pH 6.5 buffer gave a 1.15-fold higher signal/noise ratio 
than pH 6.0 (Figure 10a).   An experiment using a fixed quantity of the larger sized 
(33µm ESD) cultured alga Odontella sp. collected on 10µm nylon filters gave a 1.19-fold 
higher signal/noise ratio in pH 6.5 buffer relative to pH 6.0 (Figure 10b).  Tests using San 
Francisco Bay ballast water collected on 10µm nylon filters have shown that pH 6.5 
buffer gives 1.7-fold higher signal/noise ratios than pH 6.0 buffer, on average ( individual 
values: 1.65, 1.88, 1.62, 1.66) (Figure 10c).  The difference between the signal to noise 
ratios using buffer at pH 6.0 and 6.5 is not large, as the fluorescence of both the blank 
and the signal increase with pH in close to a proportional manner.  The raw fluorescence 
of fluorescein increases by 1.8-fold by increasing the buffer pH from 6.0 to 6.5, as 
determined using sodium fluorescein standards (Figure 6).  Because the same fluorescein 
concentration is more easily detected by spectrofluorometry at pH 6.5, less sensitive 
instrumentation is needed.  For these reasons, pH 6.5 has been selected as the optimal 
buffer pH. 
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Figure 10: Incubation buffer pH tests 
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STERILIZING THE INCUBATION SOLUTION 
The optimal buffer must be able to be autoclaved to maintain sterility without 
changing the pH or effectiveness of the buffer.  Experiments comparing freshly made 
500mM sorbitol + MES-KOH pH 6 with freshly made and then autoclaved solution show 
that the autoclaved incubation solution has a slightly lower blank, probably because 
bacterial contamination has been eliminated, resulting in slightly higher signal/noise 
ratios in autoclaved buffer (Fig 11).  The pH of the solution does not change with 
autoclaving. 
 
Figure 11: Signal/noise ratios in autoclaved vs. non-autoclaved bulk FDA incubation 
buffer. 
 
TESTING THE OPTIMIZED INCUBATION BUFFER  
The final stage of incubation solution optimization includes ensuring that the 
solution can accommodate both freshwater and marine organisms.  Pulse Amplitude 
Modulated fluorometry (PAM) was utilized to gain insight into the health of marine and 
freshwater algal cells during a Bulk FDA incubation.  The following incubation buffers 
were tested: 500mM sorbitol+ 20mM MES-KOH pH 6.5, a commercially supplied 
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potassium phosphate buffer with MgCl, and the native media for freshwater (AlgaGro) 
and marine (Guillard’s marine enrichment solution, F/2 concentration) cultures.  
Tetraselmis sp. and Coscinodiscus sp., both marine cultures, and Haematococcus sp., a 
freshwater alga, were gravity filtered and gently re-suspended in the various buffers.  
Variable fluorescence was measured immediately before and after re-suspension in 
buffer, after 1 hour, and at an extended time point which varied between 2 hours and 2 
hours 35 minutes (Figure 12, Table 2).  All three cultures showed very little immediate 
change in Fv/Fm in the incubation buffers and native media.  Coscinodiscus sp. showed 
some decline in Fv/Fm in the sorbitol incubation buffer at the 1-hour and >2-hour time 
point relative the initial reading, while showing very little change in Fv/Fm over time 
after re-suspension in the marine media and a significant decrease in phosphate buffer.  
Tetraselmis sp. did not show any reduction in sorbitol buffer nor in marine media, while 
it did show a significant reduction over time in phosphate buffer.  Conversely, the 
reduction in Fv/Fm of the freshwater alga Haematococcus was more pronounced in 
sorbitol buffer than in phosphate buffer, while no significant change was observed in 
freshwater media.   
The same re-suspended samples that were used to make the PAM measurements 
described above were also inspected microscopically to see if the cells showed any 
morphological change after being re-suspended in the re-suspension solutions (Figure 
13).  Tetraselmis, a mobile, flagellated organism, stopped swimming in the phosphate 
buffer, yet remained swimming in both the sorbitol buffer and in marine media.  This 
result is consistent with the PAM data, as the Fv/Fm of Tetraselmis was markedly 
reduced in the phosphate buffer.  No visual effect was observed in the re-suspended 
solutions of Coscinodiscus and Haematococcus, as both species remained intact without 
any obvious morphological change in all three solutions.   
Results of the re-suspension experiment suggest that 500mM sorbitol + 20mM 
MES-KOH pH 6.5 causes more osmotic stress to freshwater organisms than to marine 
organisms.  However, the freshwater alga, while showed reduced variable fluorescence, 
is still intact, viable and capable of producing fluorescein at close to the expected rate. 
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Figure 12: The variable fluorescence, measured by PAM fluorometry, of freshwater 
and marine algal cultures re-suspended in Reagent A and in native media 
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Table 2: Fv/Fm values from re-suspension of marine and freshwater algal cultures 
in native media, Reagent A, and Phosphate buffer at initial, 1 hour and 2-2.5 hour 
time points 
Genus Re-suspension fluid Initial 
Fv/Fm 
1 hour 
Fv/Fm 
> 2 hour 
Fv/Fm 
Coscinodiscus 
(marine) 
Native media 0.66 0.63 0.65 
 Reagent A 0.69 0.54 0.48 
 Phosphate buffer 0.60 0.37 0.21 
Tetraselmis 
(marine) 
Native media 0.60 0.62 0.65 
 Reagent A 0.62 0.62 0.65 
 Phosphate buffer 0.45 0.24 0.14 
Haematococcus 
(freshwater) 
Native media 0.61 0.57 0.61 
 Reagent A 0.52 0.32 0.26 
 Phosphate buffer 0.67 0.55 0.57 
 
Figure 13: Bright field and epifluorescent microscope photographs of algal cultures 
re-suspended in their native media and Reagent A. 
Marine and freshwater algal culture morphology in native media and in Reagent A 
incubation buffer
Coscinodiscus sp. 
in marine media
Coscinodiscus sp. 
in Reagent A
Tetraselmis sp.  
in marine media
Tetraselmis sp.  in Reagent A
Haematococcus sp.  
in freshwater media
Haematococcus sp.  
in Reagent A
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Therefore, 500mM sorbitol stabilized with 20mM MES-KOH pH 6.5, hereafter 
called Reagent A, has been selected as the recommended reagent for Bulk FDA 
experiments.   
TEMPERATURE EFFECT 
The assay relies on the activity of esterases, lipases and proteases which, like all 
enzymes, are sensitive to temperature changes.  Generally, enzyme activity increases with 
temperature up to some temperature optimum; elevating the temperature past this 
optimum will begin to irreversibly denature enzymes, resulting in lower enzyme activity.  
The optimal temperature and temperature range that can be tolerated vary considerably 
among enzymes, but are generally close to the ambient temperature of the organism or 
environment in which the enzymes are found.  In biological systems involving enzymes, 
a predictable response to temperature is often observed which can be described by the 
Q10 coefficient (James 1953), which describes the rate of change in a biological or 
chemical system as a result of increasing the temperature by 10°C.  The Q10 coefficient 
is calculated according to the following equation, where R1 and R2 are the rates of 
activity at each respective temperature (T1 and T2): 
 
For example, if increasing the temperature from 10° C to 20° C results in a 2-fold 
increase in enzyme activity, Q10 = 2.      
Elevated temperatures increase the EA of cells or organisms being assayed and 
therefore, increase FP.  Controlling the ambient temperature is an important aspect of 
maintaining standardized incubation conditions.  Experiments presented here, including 
those which enable the prediction of live cell concentration from FP, have been carried 
out at 20°C.  The Bulk FDA technique has been designed as a portable viability assay 
that must function predictably across the range of temperatures likely to be encountered 
in the field.  If the assay is preformed at very high or low temperatures, a correction 
factor must be applied to compensate for the change in EA due to temperature.  This 
correction factor was determined empirically.  Bulk FDA incubations in acidified FSW 
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(pH 6) were loaded with a fixed quantity of cultured Tetraselmis sp. cells and incubated 
at 10, 20 and 30°C.  The resulting data was plotted on an Arrhenius plot (Figure 14) 
which shows the significant and predictable relationship between temperature and 
FP/cell.  The Q10 coefficient of 2.05 indicates a 10° C increase will cause a 2.05x increase 
in FP, which can be used as a correction factor to adjust fluorescent results generated at 
high or low temperatures. For example, if the assay is preformed at 30°C, divide the final 
FP value by 2.05 to compare with incubations preformed at 20°C. 
Figure 14: An Arrhenius plot shows the predictable relationship between FP by 
cultured Tetraselmis sp. cells and temperature 
 
 
INCUBATION TIME 
The Bulk FDA technique measures the rate of extracellular FP and is typically 
displayed in the following units:  
   
In a typical Bulk FDA incubation, this rate is observed simply as the fluorescein 
signal at the end of a set incubation time (1 hour).  The rate of FP can be studied more 
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carefully by making multiple extracellular fluorescein fluorescence measurements over 
an incubation period following the addition of FDA, as in the characterization of 
intracellular and extracellular FP experiment previously presented.  Similar experiments 
using both cultured algal cells and natural samples have shown that extracellular FP 
proceeds at close to a constant rate; i.e. doubling the incubation time will result in close 
to double the final fluorescein concentration.  Figure 15a shows that 13% more 
fluorescein is produced in the first 30 minutes than in the second 30 minutes of a 1-hour 
incubation with 200mL Moss Landing harbor water.  The signal to noise ratio increases 
as incubation time increases (Figure 15b), because the fluorescence from a sample 
increases at a greater rate than the fluorescence of a blank.  In light of these results, 1-
hour incubations are recommended whenever possible; slight deviations from a 1-hour 
incubation can be corrected for assuming a linear production of extracellular FP over 
time.  
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Figure 15: Effects of incubation time on a) FP and b) signal/noise ratios of size 
fractionated Moss Landing harbor water and Tetraselmis sp. cells, respectively. 
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INCUBATION VOLUME 
While the mass of fluorescein produced is the key aspect of the Bulk FDA 
technique, the fluorescence at the end of an incubation in Reagent A is an indicator of 
fluorescein concentration (µg/L).  The user must multiply by the incubation volume to 
convert fluorescein concentration to the mass of fluorescein produced.  Experiments were 
devised to investigate if changes to the incubation volume would result in changes to FP 
rates by a fixed quantity of cells, or if the same mass of FP would be produced regardless 
of incubation volume.  Bulk FDA incubations were performed using a constant quantity 
of cultured Tetraselmis sp. cells and 10µM FDA.  An incubation volume of 10mL 
yielded 42% higher mass FP (µg/hr) than the mean of the lower incubation volumes 
tested (Figure 16).  While normalized FP was highest with 10mL incubation volume, 
fluorescein concentration was highest in the low incubation volume samples.  Relatively 
constant mass FP rates were observed among samples with 1, 2.5 and 5mL incubation 
volumes.  Increasing incubation volume provides a greater pool of FDA available for 
hydrolysis, which may explain the increase in FP using 10 mL incubation volume.  These 
results show that this effect is not significant, especially when incubation volumes 
between 1 and 5mL are used.  The Bulk FDA assay is therefore adaptable to varying 
incubation volumes to without losing comparability among FP results.  
Figure 16: The effect of incubation volume on FP by cultured Tetraselmis sp.  cells. 
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FDA CONCENTRATION 
When enzyme activity is measured, it is customary to keep the substrate of the 
enzymes being assayed in excess.  Using this approach, the amount of substrate that is 
converted to product is proportional to enzymatic activity only, rather than being 
proportional to the substrate concentration and enzyme activity.  One can determine the 
concentration at which the substrate becomes limiting for a given enzymatic assay by 
titrating the substrate concentration, incubating in the presence of enzyme and recording 
the concentration of product formed at each substrate concentration.  A plot of substrate 
concentration vs. product formation will show the concentration at which substrate is 
limiting.  At areas of the plot where increasing the substrate concentration causes an 
increase in product formation, the substrate is limiting, as the amount of product 
formation depends on both the enzyme activity and the substrate concentration.  When 
substrate is in excess, further increases in substrate concentration do not result in an 
increase in product formation; the amount of product formation depends only upon 
enzyme activity.   
To test the effect of FDA concentration, Bulk FDA experiments were performed 
using cultured Tetraselmis sp. cells and Moss Landing harbor.  Constant biomass levels 
were loaded onto GF/F filters and incubated in Reagent A buffer across a range of FDA 
concentrations (1-500 µM FDA) (Figure 17).  To control for any effect of the solvent in 
which the FDA stock is dissolved (DMSO), varying concentrations of stock FDA were 
prepared such that the same volume of DMSO (10µl) was added to each sample.  
Increasing the FDA concentration results in an increase in product formation until an 
FDA concentration of about 25µM, after which increasing the concentration above 25µM 
does not cause an increase in FP.  This suggests that  FDA is in excess at around 25µM; 
FDA would therefore ideally be added at a concentration greater than or equal to 25µM.  
However, the signal/noise ratio is highest at 10µM (Figure 17b).  Breeuwer et al., 1995 
report that the maximum concentration of FDA that can be dissolved in aqueous solvents 
is 10µM; if more FDA is added a visible precipitate will form.  Precipitated FDA will not 
serve as a substrate for esterase activity unless it re-dissolves.  Because the re-dissolution 
of FDA is a potentially variable process that could decrease the precision of the assay, 
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Figure 17: The effects of FDA concentration on FP by Tetraselmis sp. cells and Moss 
Landing harbor water. 
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and greatest sensitivity (signal/noise) is achieved at 10µM FDA,  10µM has been 
selected as the optimal FDA concentration. 
When the Bulk FDA assay is carried out using 10µM FDA and an incubation 
volume of 2.5mL, 25nmols of FDA are added.  A typical, 1-hour Bulk FDA incubation 
using 10µM FDA, will produce between 0.038 - 7.5 nmols.  The lower limit of this range 
(0.038nmols FP) corresponds to a signal 5-fold higher than the blank.  The upper limit 
(7.5nmols FP) corresponds to the highest fluorescence that can be detected reliably using 
the SPEX Fluoromax 2 fluorometer; loading biomass at high levels which results in 
fluorescence above this limit is avoided.  This shows that between 0.15-30% of the FDA 
added is converted to fluorescein, based on a 1:1 stoichiometric relationship between 
FDA and fluorescein.    
SAMPLE AGITATION BEFORE AND DURING THE BULK FDA INCUBATION   
The effects of vortexing samples at the beginning and end of the Bulk FDA 
incubation were investigated, as well as the effects of continually agitating the samples 
during incubation.  Vortexing serves to quickly and efficiently homogenize the FDA 
within the incubation buffer, as well as removing cells off the filter that was used to 
harvest cells. Figure 18 shows that vortexing for 5 seconds actually lowers the FP 
produced by natural samples (Moss Landing harbor water) by roughly 25% relative to 
using multiple gentle inversions to mix each sample.  Vortexing may harm cells in some 
way and, therefore, is not recommended.   
A test of constant mixing during the incubation vs. mixing only at the start of the 
incubation was performed using cultured Tetraselmis sp. cells.  Samples were mixed by 
inverting only and left to incubate without agitation, while identical samples were mixed 
by inverting and then placed on a mechanical mixer, which agitated samples using a back 
and forth rocking motion.  5 different biomass levels were loaded and 4 of the 5 showed 
greater FP without rocking; FP was an average of 73% higher in non-agitated samples 
(Figure 19).  Agitation during the Bulk FDA incubation is not recommended.   
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Figure 18: The effects of vortexing after adding FDA and before making the 
fluorescent measurement 
 
 
Figure 19: The effect of agitating identical samples on a mechanical "rocker" 
during the bulk FDA incubation 
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ALKALIZING THE INCUBATION BUFFER TO INCREASE FLUORESCEIN 
FLUORESCENCE 
Fluorescein fluoresces most intensely at or above pH 8.0.  Increasing the 
sensitivity of the assay was a primary goal of the optimization process, therefore it seems 
logical to measure fluorescence near pH 8.   It has been consistently shown, however, that 
abiotic FP increases drastically with increasing pH, which lead to the selection of pH 6.5 
Reagent A as the optimal  
incubation buffer.  To minimize abiotic FP but increase fluorescein fluorescence, 
attempts were made to alkalize the incubation buffer above pH 8.0 at the end of the 
incubation by adding basic reagents.  0.1 N NaOH and the 1M solutions of the basic 
organic buffers Trizma, Tricine and AMPD were tested.  Titration curves were prepared 
to determine the correct quantity of base to add to Reagent A (pH 6.5) to raise the pH to 
8.1.  NaOH addition caused complete conversion of all FDA to fluorescein, rendering the 
fluorescence from all samples and blanks identical.  The organic base additions increased 
fluorescence of both samples and blanks in a proportional manner, resulting in more 
easily detected fluorescent signals and similar signal/noise ratios relative to non-alkalized 
samples when the measurement was made immediately following the addition of the base 
(Figure 20a).   Of these alkalizing agents, Trizma proved to yield the highest increase in 
fluorescein fluorescence and best preservation of signal/noise ratios.  Variability among 
replicate samples did not significantly increase following the addition of the base, 
suggesting that the increase in fluorescein fluorescence upon the addition of base is 
consistent and predictable.  However, FP from abiotic sources increases markedly after 
the pH increase, resulting in very high blank fluorescence and an unacceptable reduction 
in signal/noise ratios if the fluorescent measurement is not made immediately (Figure 
20b).    To minimize abiotic FP, the addition of Trizma is only recommended under 
conditions where sensitivity is the primary priority and measurements can be made 
immediately after the addition of base.        
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Figure 20: A test of Bulk FDA sample alkalization with Trizma organic base after 
incubation, before fluorescent measurement a)signal/noise ratio and b) fluorescein 
fluorescence over time 
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Characterization of the Bulk FDA technique 
The fundamental aspect of the Bulk FDA assay, that FP is proportional to living 
biomass and not dead biomass, is confirmed by experiments presented below involving 
both cultured organisms and natural samples using the optimized form of the technique.  
Empirical relationships are elucidated between FP, measured under the standardized, 
optimized conditions, and other commonly used measures of living biomass.      
FLUORESCEIN PRODUCTION FROM STERILIZED SAMPLES 
Moss Landing Harbor water was treated with 0 (control), 12, and 60 ppm sodium 
hypochlorite and extracellular FP was measured at multiple time points during a Bulk 
FDA incubation (Figure 21).  FP proceeds at a constant rate in the untreated sample, 
while FP is barely detectable above the blank in the treated samples.  An experiment 
testing the effect of duration in the high temperature treatment (70ºC) revealed that 
increasing incubation time did not affect FP; similar FP was observed in samples held in 
hot water for 2, 15, 30 and 60 minutes (Figure 22).  These results show that reduction of 
viable biomass by known kill factors results in decreased FP. 
Figure 21: The effect of 0 (control), 12, and 60ppm sodium hypochlorite on FP from 
Moss Landing harbor water 
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Figure 22: The effect of duration in a hot water bath (70°C) spent by Dunaleilla sp. 
cells prior to being assayed for bulk FDA. 
 
TYPES OF ORGANISMS THAT CAN BE DETECTED 
Because esterases are ubiquitous enzymes, the Bulk FDA should, in theory, be 
able to detect EA from any organism.  Most of the optimization tests were performed 
using algal cultures or natural samples likely to contain phytoplankton and/or 
microzooplankton, demonstrating the applicability of the assay for these organism types.  
Additional tests were done to investigate if EA from other types of organisms could be 
detected.  Zooplankton were collected by net tow in Moss Landing Harbor, and 
individual zooplankters, mostly copepods in nauplii or mature stage, were picked out 
with forceps, placed in incubation buffer and assayed for Bulk FDA.  Fluorescent 
measurements were made over time after addition of FDA (Figure 23); FP from single 
zooplankters was 40-fold higher than the blank after a 1-hour incubation, indicating that a 
single zooplankter produces an easily detected signal with the Bulk FDA technique.   
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Figure 23: Bulk FDA viability of single copepods 
 
 
Little attention in this study was given to the assay of terrestrial organisms, 
however, in one instance, ants and bugs (unidentified) were collected and incubated in 
the same manner as described for zooplankton above (Figure 24).  Both the two ants and 
single bug showed significantly more FP than the blank after 1-hour.  Door handles were 
swiped around the lab with GF/F filters in an effort to collect bacteria and other 
microorganisms; the filters were then assayed by Bulk FDA in the usual manner.  The 
signal from swiped filters was variable and slightly higher than the blank in most cases; 
swiped filters generated signal/blank FP ratios ranging from 1.3- 6.6 (Figure 25).   
Marine bacteria were cultured by streaking Moss Landing harbor water onto 
Difco  marine agar plates.  The following day, single and multiple colonies were picked 
off, placed in incubation buffer and assayed for Bulk FDA.  Single colonies produced 25x 
more fluorescence than the blank after a 1-hour incubation (Figure 26).  Loading more 
colonies resulted in proportionally more FP.  The number of bacteria cells present in each 
colony was unknown.  The quantity of FP per bacteria cell was investigated more closely 
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Figure 24: Bulk FDA viability of terrestrial insects were collected outside Moss 
Landing Marine Laboratories 
 
 
Figure 25: Door handles at Moss Landing Marine Laboratories were swiped with 
GF/F filters to collect bacterial contamination and were assayed for bulk FDA 
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Figure 26: Bulk FDA viability of marine bacteria cultivated on marine agar plates 
 
by utilizing bacteria present in non-axenic algal cultures.  Algal cells were 
removed by filtration from several freshwater and marine algal cultures and the 
concentration of bacteria was determined using flow cytometry and the  green fluorescent 
DNA stain SYTO-13.  Bacteria cells were then captured on GF/F (nominal 0.7µm pore 
size) filters and assayed for Bulk FDA.  It is possible that some smaller bacteria cells 
could have slipped through the GF/F filter; only bacteria >0.7 µm were assayed.  
Cultured Synechococcus cells, which are photosynthetic marine cyanobacteria 1.7µm in 
diameter, were counted by flow cytometry and assayed in the same manner.  Using the 
assumption that all the bacteria which contributed towards the flow cytometric count 
were collected on the GF/F, marine and freshwater bacteria FP was equal to 1.46 and 
0.79 fg/cell.hr, respectively, while Synechococcus FP was equal to 1.79 fg/cell.hr (Figure 
27). 
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Figure 27: Fluorescein production rates per cell of marine and freshwater bacteria 
isolated from non-axenic algal cultures and of the cultured cyanobacteria 
Synechococcus 
 
GROWTH EXPERIMENT 
An experiment was designed to test if the Bulk FDA technique could measure the 
growth rate of an algal batch culture.  This experiment also investigated if FP per cell 
changed as the culture grew.  A large volume (2L)  batch culture of the unicellular alga 
Tetraselmis sp. was inoculated and monitored over a period of 36 days.  Every few days 
the culture was mixed and a small volume was removed to measure the bulk biomass 
indicator, FP, and the numeric concentration of live cells by flow cytometry (FC).  
Measurements of both parameters over time were plotted as growth curves in which the 
natural logarithm of the live indicator per unit volume (i.e. live cells/mL or FP/mL 
filtered) was plotted against the days after inoculation; the slope of the linear regression 
of these plots is the effective growth rate, µ (Figure 28a).  Between Day 25 and 36, the 
cell concentration actually decreased, therefore, Day 36 is not included in the growth  
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Figure 28: The growth rate of a batch Tetraselmis sp. culture measured by flow 
cytometry (numeric cell concentration) and bulk FDA (bulk biomass indicator) over 
the a) entire growth period, b) first 15 days, c) and last 10 days 
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plots.  Over the 25 days of growth, the FC generated µ=0.256  while the Bulk 
FDA µ=0.204.   
Breaking the plot into two sections provides insight into this discrepancy.  From 
Days 4-15 the two methods provide nearly identical measurements of growth rate (FC 
µ=0.343, Bulk FDA µ=0.346) (Figure 28b).  From Day 15-25 the FC growth rate is 
nearly double the Bulk FDA growth rate  (FC µ=0.155, FP µ=0.079) (Figure 28c).  
Clearly, the cells are growing more slowly during this second phase of the experiment, 
and slowing of the growth rate is more pronounced when measured by Bulk FDA.   
The difference between the growth rate estimated by FC and by Bulk FDA during 
days 15-25 of growth can be explained by investigating the FP/cell ratios over time 
(Figure 29).  The FP/cell over the first 15 days after inoculation is variable but without an 
evident trend, as individual values range from 1.78-2.99 pg/cell.hr.  From days 19-36, the 
FP/cell drops considerably and does not recover, ranging from 0.58-1.11 pg/cell.hr.  
During this second phase of the batch culture, the decrease in FP/cell ratios leads to lower 
estimates of growth rate by Bulk FDA relative to the numeric count.  The decrease in 
FP/cell observed over time was not due to a decrease in cell volume, as the size of cells, 
measured by the forward scatter detector of the flow cytometer, did not change 
significantly during the growth period (Figure 30).  These results show that the FP/cell of 
a single species can vary by 5-fold depending on the ambient conditions.  Nutrient 
deprivation is likely to be a main cause of the observed decrease in FP/cell, while it is 
possible that self-shading or some unknown factor could contribute as well.                      
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Figure 29: The FP/cell rate of a Tetraselmis sp. batch culture over time. 
 
 
Figure 30: The relative cell size of a Tetraselmis sp. batch culture over time, given as 
the mean forward scatter signal of an Accuri C6 flow cytometer. 
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MONTEREY BAY DATASET: BULK FDA, ATP, LIVE CELL CONCENTRATION 
Correlation of fluorescein production with ATP  
Natural samples were collected along the coast in Pacific Grove, Monterey and 
Moss Landing, as well as from Moss Landing harbor.  Some samples were manipulated 
to reduce or increase ambient viable biomass.  Sodium hypochlorite was used at several 
concentrations to reduce viable biomass.  Samples were treated with Guillard’s marine 
enrichment solution and incubated in a temperature controlled illuminated incubator 
(15°C) to increase viable biomass.  Controls for nutrient enriched samples included a 
sample placed in the illuminated incubator without nutrients and a sample in the dark 
without nutrients.  The nutrient enrichment treatment also serves to mimic nutrient 
variability expected in nature, such as a pulse of nutrients from upwelling or terrestrial 
sources.  FP, ATP and live cell concentration (10-50 micron ESD) by FDA flow 
cytometry were measured on each of the coastal samples.  
Log-log (base 10) plots were made to establish the relationship between ATP and 
FDA, as the data spanned several orders of magnitude.  Linear regression of log(ATP) vs. 
log(FP) values from this sample set reveals a positive, relatively constant relationship 
with the following equation (Figure 31):  
    
The slope <1 of the above regression reveals that ATP data span a greater range 
than FP.  ATP ranges over slightly more than 3 orders of magnitude, while FP values 
range over 2 orders of magnitude.  Non-manipulated samples showed FP (ng/L.hr)/ATP 
(ng/L) ratios between 0.74-7.24 with a mean of 1.87.  Samples manipulated with low 
levels (0.12-6 ppm) of hypochlorite showed slightly higher FP/ATP ratios (range 1.11-
10.7, mean = 3.28), as the reduction in ATP was more pronounced than in FP.  The 
samples treated with high bleach concentration (60 ppm) showed disparity between the 
decrease in ATP and in FP, which results in the highest ratio (FP/ATP) values and 
highest variance observed in this study (range 4.7-107, mean 35.8).  The nutrient 
enriched samples showed proportional increases in ATP and FP, which results in FP/ATP 
ratios (mean 1.8) similar to the non-manipulated samples. 
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Figure 31: The relationship between FP and ATP from manipulated and non- 
manipulated coastal samples 
 
Additional samples were collected aboard the Research Vessel Point Sur at 
several sites offshore in Monterey Bay on March 28-29th, 2012 to further investigate the 
relationship between ATP and Bulk FDA.  Samples were taken at multiple depths in the 
water column (surface to 4000 m) using a CTD rosette, and processed for ATP and FP 
shortly after collection.  The relationship is again relatively consistent and the plot of 
log(ATP) vs. log(FP) reveals the following equation (Figure 32): 
    
  Again, the ATP dataset ranges over 4 orders of magnitude, while the Bulk FDA 
values only range over 3 orders of magnitude, resulting in a slope on the log-log plot < 1.  
FP (ng/L.hr)/ATP (ng/L) ratios were variable among these samples, ranging from 0.82-
41.  However, no trend was observed in the FP/ATP ratio with depth. 
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Figure 32: The relationship between FP and ATP from water column profile 
samples (surface-4000m) collected in Monterey Bay, March 2012 
 
Correlation of fluorescein production with numeric concentration of live cells 
10-50 µm  
The relationship among coastal samples between FP and live cell concentration 
measured by flow cytometry is positive and relatively constant.  Linear regression of the 
log-log plot between FP and live cell concentration (both manipulated and non-
manipulated samples) reveals the following equation (Figure 33):   
 
The slope <1 of the above log-log regression reveals that live cell concentration 
varies over a greater range than FP.   
The empirical measurements of FP and live cell concentration allow one to 
estimate a per cell (10-50 µm ESD) FP rate.  A histogram (Figure 34) shows the 
frequency of FP/cell values observed among these samples; FP/cell values in the range 0-
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1 pg/cell.hr were the most commonly observed.  Non-manipulated samples showed FP 
(pg/cell.hr) values between 0.37-18.0 with a mean of 2.70.  Samples manipulated with 
low levels (0.12-6 ppm) of hypochlorite showed elevated FP (pg/cell.hr) values (range 
0.4-19.4, mean = 6.32) relative to non-manipulated samples, as live cell concentration 
decreased more drastically than FP.  Samples treated with high bleach concentration (60 
ppm) all scored 0 live cells according to the cytometric technique, prohibiting one from 
calculating the per cell FP.  The nutrient enriched samples and illuminated controls 
showed greater increases in FP than in live cell concentration, resulting in FP (pg/cell.hr) 
values of 1.44 and 1.22 respectively, which were higher than the FP (pg/cell.hr) of the 
dark, non-enriched control (1.19).  These results suggest that the per cell FP increases 
upon the addition of light and increases most drastically when light and nutrients are 
provided.   
 
Figure 33: The relationship between FP and live cell concentration measured by 
flow cytometry from coastal Monterey Bay samples (10-50µm size class) 
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Figure 34: Histogram of FP/10-50μm cell ratios observed among coastal Monterey 
Bay samples 
 
DETERMINATION OF THE RELATIONSHIP BETWEEN CELL VOLUME, FLUORESCEIN 
PRODUCTION AND ATP USING ALGAL CULTURES 
In order to determine the FP/cell rate from unicellular algal cultures of known cell 
volume, an experiment was performed in which FP, cell concentration, ATP, and cell 
volume were measured simultaneously from all freshwater and marine algal cultures 
cultivated in the laboratory (listed in Table 1).  The resulting dataset was analyzed using 
linear regression between the measured parameters.  To accommodate the large ranges in 
biomass measured, the logarithm (base 10) of each parameter was taken and used to 
create plots for regression.   
Fluorescein production and cell volume 
Linear regression of log(cell volume) and log(FP) reveals the following equation:   
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Although variation exists among the strains tested, it is clear that a significant and 
positive relationship exists between FP and cell volume (Figure 35a).  The slope <1 on 
the log-log plot shows that cell volume varies over a wider range than FP.  FP/µm
3
 ratios 
are lower for the largest cultures, causing the FP values to span over a narrower range 
than cell volume.  Individual FP/µm
3
 ratios ranged from 0.12 - 7.48 fg/hr.µm
3 
 for 
Coscinodiscus (cell volume = 792,000µm
3
) and Chlorella (cell volume = 62µm
3
), 
respectively.  A plot of FP/µm
3
 ratios vs. cell volume, Figure 35b, shows a trend of 
declining FP/µm
3
 ratios with increasing cell volume.  No clear trend was observed 
between freshwater and marine cultures; both types of algae showed comparable FP/µm
3
 
ratios, which suggests that the EA of both freshwater and marine phytoplankton are 
similarly affected by the buffer.   
 
Figure 35: a) The relationship between cell volume and fluorescein production per 
cell per hour of each cultured alga b) the relationship between FP/μm3 and cell 
volume 
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ATP and cell volume 
Linear regression of log(ATP) and log(cell volume) reveals the following 
equation:   
 
A significant and positive relationship clearly exists between the ATP and cell 
volume (Figure 36a).  The slope <1 on the log-log plot shows that cell volume does vary 
over a wider range than ATP, but to a lesser extent than FP and cell volume.  The R
2
 
value is also higher than in the cell volume vs. FP regression; these results show that ATP 
correlates more closely with cell volume than FP does.  Individual ATP/µm
3
 ratios were 
less variable than FP/µm
3
 ratios, ranging from 25 - 517 pg/µm
3 
 for Coscinodiscus 
(792,253µm
3
) and Haematococcus (134µm
3
), respectively.  A plot of cell volume vs. 
ATP/µm
3
 ratios, Figure 36b, reveals a trend of decreasing ATP/µm
3
 ratios with 
increasing cell volume.    
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Figure 36: a) The relationship between cell volume and ATP concentration for each 
cultured alga b) the relationship between ATP/μm3 and cell volume 
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Fluorescein production and ATP 
Linear regression of log(FP) and log(ATP) reveals the following equation:   
 
As expected, a significant and positive relationship exists between FP and ATP 
(Figure 37).  The slope <1 on the log-log plot shows that ATP varies over a wider range 
than FP, which was expected based on the relationships that FP and ATP show with cell 
volume.  Individual FP/ATP ratios ranged from 2.2 - 34 (fg FP/hr)/(fg ATP) for 
Helicotheca tamensis (8,064µm
3
) and Dunaliella sp. (434µm
3
), respectively.  
Chlorophytes generally show higher FP/ATP ratios (including Dunaliella, Tetraselmis, 
Chlorella, Staurastrum), while other taxa, mostly diatoms, show lower FP/ATP ratios.  
No significant difference was observed in the FP/ATP ratios between freshwater and 
marine algal cultures.   
Figure 37: The relationship between ATP/cell and FP/cell.hr for each cultured alga. 
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Method detection limit and precision of the Bulk FDA technique 
The method detection limit (MDL) of the Bulk FDA assay was determined by 
following the protocol outlined by Skoog, et al in his book, Principles of Instrumental 
Analysis.  Approximately 6,000 Tetraselmis sp. cells were filtered onto GF/F filters (n=9) 
and processed for Bulk FDA using the optimized protocol (n=9).  Samples were 
measured on the high sensitivity SPEX fluorometer and handheld Aquafluor fluorometer.  
Cell-free blanks were included and used to correct sample fluorescence.  The standard 
deviation of samples, in units of fluorescein concentration, was 0.09 and 0.30 μg/L on the 
SPEX and Aquafluor fluorometer, respectively.  These standard deviations are multiplied 
by the 1-sided t-value for 8 degrees of freedom (2.896) to yield the MDLs of 0.26 and 
0.87μg/L fluorescein on the SPEX and Aquafluor fluorometers, respectively.  2.5mL 
incubation volume is typically used; multiplying each MDL by the incubation volume 
reveals that 648 and 2,166pg of FP can be detected by the SPEX and Aquafluor 
fluorometers, respectively.  If we consider, for example, that 15μm is the most likely 
mean cell size of a 10-50μm ballast water sample, and we know the expected FP rate by a 
15μm cell is 1.91 pg/cell.hr, we calculate that 339 and 1,134 cells must be harvested to 
reach the method detection limit when using the SPEX and Aquafluor fluorometers, 
respectively. 
The datasets in which ATP and Bulk FDA were measured from identical samples 
in replicates, including algal cultures, coastal Monterey Bay samples and ballast water 
samples, were used to compare the precision of the two assays (Table 3).   The precision 
of the Bulk FDA technique, calculated as the coefficient of variation (CV):  
%100*(%) 






mean
SD
CV  
 was higher than the extraction and measurement of ATP for all 3 datasets.  The 
Bulk FDA assay typically has a coefficient of variation (CV) ≤ 10%, however, including 
treated and therefore low biomass samples as in the coastal and ballast samples results in 
CVs >10%. 
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Table 3: The precision of the Bulk FDA and ATP assays observed from 3 distinct 
sample sets 
Sample set n Bulk FDA 
CV (%) 
ATP 
CV(%) 
Algal cultures 4 5% 14% 
Monterey Bay coastal 
samples 
3 9% 17% 
Ballast samples 3 23% 27% 
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DISCUSSION 
Fluorescein Budget: Intracellular vs. Extracellular 
In Bulk FDA incubations with cultured algal cells, roughly 97% of the total 
fluorescein produced (intracellular + extracellular) is present in the extracellular solution 
after a 1-hour incubation.  However, several factors could cause this estimation of 
intracellular and extracellular fractions to be inaccurate.  It is possible that more 
fluorescein is present in the intracellular fraction than estimated above, but that the 
measurement of fluorescein is more efficient in the extracellular medium than inside 
cells, resulting in an underestimation of the relative proportion of intracellular 
fluorescein.  The cell wall, plasma membrane or other cellular structures could optically 
interfere with the measurement of intracellular fluorescein fluorescence.  It is also 
possible that mechanical stress caused by the processes to remove cells, centrifugation or 
filtration, could cause cells to release some or all of their intracellular fluorescein into the 
extracellular solution, resulting in an underestimation of the intracellular fraction.  
Conversely, the intracellular fraction could be overestimated if the cytoplasmic pH 
exceeds that of the extracellular buffer (pH 6.5), as fluorescein fluoresces more intensely 
as pH increases.  In either case, it is more sensitive and reproducible to measure 
extracellular fluorescein, thereby eliminating any variability caused by the intracellular 
fraction, and the technique has been devised to measure fluorescein in Reagent A buffer.  
pH and abiotic fluorescein production 
During the optimization experiments, it became clear that pH is important for 
many aspects of the Bulk FDA assay.  Fluorescein fluorescence is very dependent on pH, 
the fluorescence of a single standard ranges 56 times between pH 3.9 and 8.  This 
relationship gives the user power to increase or decrease the fluorescence of a sample or 
standard by adjusting pH.  A primary goal of the optimization process is increasing 
sensitivity; the usefulness of the assay is proportional to its ability to reliably measure 
low biomass levels.  Therefore, it is logical to measure the fluorescent result of the assay 
at the optimum pH for fluorescein fluorescence.  However, incubating a sample at high 
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pH has drawbacks that counteract sensitivity gains in the intensity of fluorescein 
fluorescence.   
High abiotic FP was observed in the majority of incubation buffers tested here.  
Clarke et al. 2001, when attempting to devise a protocol for measuring bulk microbial 
activity in commercial products using FDA, observed high amounts of abiotic FP in all of 
the incubation buffers and bacterial growth medium tested, and concluded that no 
acceptable incubation buffer had currently been found.  The results presented here show 
that abiotic FP is correlated with pH to an even greater extent than fluorescein 
fluorescence.  The increased efficiency of fluorescein fluorescence at elevated pH does 
contribute towards the increase in abiotic FP, however, abiotic FP increases to a greater 
extent than could be due to the increased efficiency of fluorescein fluorescence alone.  
Between pH 7 and 8, for example, fluorescein fluorescence increases by 1.3-times, while 
abiotic FP from an incubation with FDA increases by 13-times.  When using incubation 
buffers above pH 7, this increase in abiotic FP results in reduced signal/noise ratios, as 
abiotic FP increases more drastically than biological FP between pH 7-8.  When using 
incubation buffers between pH 6 and 7, both blank and sample fluorescence increase 
proportionally, resulting in signal/noise ratios that are similar within this range.   
In an effort to minimize abiotic FP while maximizing the sensitivity of the assay, 
it was proposed that the sample could be alkalized at the end of the incubation and 
immediately before making the fluorescent measurement.  Approximate 1.6-times 
increases in the sample and blank fluorescence were observed immediately after adding 
the base, which raised the pH from 6.5 to 8.1.  This step can be useful for users 
demanding greater sensitivity, such as those using an insensitive fluorometer.  Care must 
be taken, however, to make this measurement as soon as possible after adding the base to 
avoid false positives, as the rate of FP increases rapidly after the addition of base.  If the 
measurement is not made immediately, samples without any viable biomass, such as a 
cell-free blank or successfully sterilized sample, will show significant rates of FP, which 
could lead to the conclusion that the sample contained viable biomass.  Therefore, 
alkalization of samples is not recommended for typical execution of the Bulk FDA assay.      
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Temperature and the Bulk FDA assay 
The Bulk FDA assay is an indicator of enzyme activity, therefore, it should 
respond to changes in temperature like kinetic enzyme models predict.  The Q10 
coefficient for enzyme catalyzed reactions, such as FDA hydrolysis, is typically 2-3 
(Quinlan 1980).  Rotman and Papermaster (1965), while studying the hydrolysis of FDA 
by mammalian cells, found that Q10 =1.78 for the intracellular accumulation of 
fluorescein.  The Q10 coefficient observed in this study for extracellular FP by 
Tetraselmis sp. (2.05) is well within the expected range.  The enzymes hydrolyzing FDA 
perform as expected in response to temperature, which suggests that extracellular FP is a 
direct indicator of cellular EA and the dependence of the Bulk FDA assay on FDA influx 
and fluorescein leakage through cell membranes does not compromise this relationship. 
This finding also implies that the esterases are not denatured by the pH or temperature 
present during the incubation.  The predictable response of FP with temperature greatly 
improves the convenience of the assay; it can be performed at any temperature likely to 
be encountered and, as long as that temperature is known, the result can be corrected 
using the empirically determined Q10 relationship.       
Incubation time 
The rate of extracellular FP slows slightly over time during a  Bulk FDA 
incubation.  This could be caused by reduction in the cell membrane chemical gradients 
for FDA and fluorescein as FDA is converted to fluorescein.  Depletion of extracellular 
FDA during the incubation will weaken the chemical gradient for FDA influx, while the 
chemical gradient of fluorescein efflux will decrease as extracellular fluorescein 
concentration climbs.  Also, the rate of extracellular FP is expected to decrease after the 
cells being assayed have completed their phase of descending intracellular fluorescein 
concentration.  The gradual slowing of extracellular FP during an incubation suggests 
that natural assemblages may have largely completed this descending phase after 1-hour.  
A 1-hour incubation improves signal/noise ratios and produces more readily detected 
fluorescent signals relative to shorter incubation times, and, for these reasons, has been 
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selected as the optimal incubation time.  Varying incubation times close to 1 hour can be 
corrected for assuming a linear production of FP over time.  
FDA concentration 
One drawback of using FDA is that it has limited solubility in aqueous solvents 
(10µM) (Breeuwer et al., 1995).  The increase in FP that is observed at FDA 
concentrations greater than 10µM is likely due to re-dissolution of precipitated FDA 
during the incubation period.  Based on the maximum solubility of FDA, when FDA is 
added to Reagent A at 25µM, for example, approximately 10µM of the FDA is dissolved 
and 15µM is precipitated.  As the enzymatic reaction proceeds, some of the dissolved 
FDA is converted to fluorescein, thus reducing the dissolved FDA concentration below 
10µM.  As much as 30% of the FDA that is added to a Bulk FDA incubation is converted 
to fluorescein after 1 hour under typical conditions.  This depletion could allow some of 
the precipitated FDA to re-dissolve and become substrate for esterase activity, essentially 
serving as a source of FDA to replenish the dissolved substrate, resulting in more FP at 
the end of the incubation.  Adding FDA at concentrations exceeding 10µM can be seen as 
an improvement to the assay because the substrate is in excess and a higher fluorescent 
signal is achieved with the same biomass loaded.  However, abiotic FP increases more 
than biological FP at elevated FDA concentrations, resulting in a decreasing in 
signal/noise ratio.  Also, the re-dissolution of precipitated FDA is likely a variable 
process, depending on the incubation temperature, amount of agitation to the samples 
during the incubation and possibly other factors.  If the amount of precipitated FDA that 
becomes re-dissolved is variable between experiments, the relationship between the 
viable biomass loaded into the reaction vessel and FP will become more variable as well.  
In an effort to eliminate FDA concentration as a source of variability, it is recommended 
that FDA be added at 10µM.     
Algal health in incubation buffer 
Results from PAM measurements of cultures re-suspended in various incubation 
buffers suggest that 500mM Sorbitol + 20mM MES-KOH pH 6.5 likely causes some 
osmotic stress to freshwater organisms, and is better suited osmotically to accommodate 
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marine organisms.  The freshwater alga, Haematococcous, showed reduced Fv/Fm values 
indicative of stress, yet remained intact, viable (Fv/Fm > 0.2) and capable of producing 
fluorescein at close to the expected rate, suggesting that this physiological stress caused 
by the incubation buffer may not cause changes in cellular EA.  It is encouraging that the 
marine organisms showed little or no reduction in Fv/Fm.  Tetraselmis sp. remained 
swimming in Reagent A, indicating that no major physiological change occurred during 
the incubation. 
Effects of nutrients and light on cellular esterase activity  
  The growth experiment, using a batch culture of Tetraselmis sp., shows that 
during the period of exponential growth, the FP/cell ratio is relatively constant, making 
the Bulk FDA technique an excellent predictor of cellular growth rate.  However, after 
this initial phase, the FP/cell decreases, which leads to an underestimate of the growth 
rate by Bulk FDA relative to that calculated from numeric counts (flow cytometry). 
Possible reasons for the decrease in FP/µm3 include self shading by the culture as it 
became more dense, resulting in less light exposure, or nutrient depletion.  This study 
showed that the FP/10-50μm cell increased when Moss Landing Harbor water was 
enriched with nutrients and placed in an illuminated incubator relative to a non-enriched, 
dark control.  Brookes et al. (2000) found that EA/cell, defined as the rate of intracellular 
fluorescein accumulation measured by flow cytometry, was positively correlated with the 
light intensity used to culture cells.  The same study also showed that EA/cell of nutrient 
limited cultures increased dramatically 1 day after the addition of the limiting nutrient 
(nitrogen or phosphorous).  The quantity of ATP/cell has also been shown to decrease in 
nutrient limited algal cultures and increase 1 day following nutrient addition (Holm-
Hansen 1970); the same study showed that light stimulated increases in cellular ATP.  
The finding that FP/cell correlates with the light and nutrient status of the cells is useful 
for making comparisons between FP from algal cultures and from natural samples.  Cells 
in most natural environments are likely to be both nutrient limited (Howarth 1988) and 
light limited (Sunda et al. 1997), therefore, the FP/cell ratios observed in nutrient 
depleted, self-shaded cultures are likely more relevant for predicting the rate of FP/cell 
from natural samples.  
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Fluorescein production and ATP per biovolume as a function of 
cell size 
The relationship between biovolume and FP was investigated by measuring the 
FP/cell from many different algal cultures spanning a wide size range, from 
Synechococcus (2.56µm3/cell) to Coscinodiscus (582,000µm3/cell).  This study revealed a 
general trend of decreasing FP/µm3 as cell size increased, ranging from 0.12 fg/hour.µm3 
by Coscinodiscus to 7.8 fg/hour.µm3 by Chlorella (62 µm3/cell), which results in a 
positive y-intercept on the plot of cell volume and FP (Figure 41).  ATP was measured in 
tandem with Bulk FDA, and, interestingly, showed the same trend of decreasing 
ATP/µm3 as cell size increased (Figure 42).  This trend could be due in part to the fact 
that large sized algal cells have more vacuolar space than small cells.  Vacuoles in algal 
cells are the sites of protein degradation and turnover, as well as providing cellular 
structure and immune function (Becker 2007).  This vacuolar space contributes to cell 
volume but not to cellular carbon (Strathman 1967), and is likely to be less densely 
packed with esterase and ATP than in other areas of the cell (Verity 1992).  It appears 
that smaller cells are more efficient at packing enzymes and ATP in a small intracellular 
space, while larger cells have more open intracellular space and less enzyme and ATP per 
unit cell volume, resulting in the trend of decreasing FP/µm3 and ATP/µm3 with 
increasing cell size observed in this study.  It is also true that FP from large cells could be 
limited by FDA influx.  Small cells have a higher surface area/volume ratio than large 
cells; FDA that enters cells will be exposed to the total pool of cytoplasmic esterases 
more rapidly in small cells than in large cells, which could result in underestimation of 
true cellular EA from large cells by the Bulk FDA technique.   
Fluorescein production as a predictor of cell concentration 
Regulatory standards for treated water, such as drinking water or ballast water, are 
defined as numeric concentration of viable cells in a defined size range.  Ballast water 
discharge standards, for example, state that water to be discharged in a non-native port 
contain no more than 10 viable cells/mL for organisms 10-50µm (IMO G8, 2008).  The 
relationship between FP and cell volume established by this study allow one to predict 
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the expected FP per cell rate for any sized cell.  One can use this predicted FP/cell rate to 
convert a Bulk FDA assay result to a prediction of living cell concentration after 
assuming a single mean cell size for the sample.  For example, for a size fractionated 10-
50µm sample, one could assume that all living cells present in the sample are 10µm ESD 
(or, rather, that the mean cell size is 10µm ESD) and divide the FP result by the FP/cell 
rate of a 10µm cell to calculate the predicted cell concentration (cells/L).  One could then 
follow the same logic under the assumption that all cells in the size fractionated sample 
were 50µm.  This approach provides a generous and conservative estimate of 
concentration of living cells, which is useful for the testing of regulated water sources 
such as ballast water.     
The validity of this approach can be investigated by comparing the FP/cell rates 
of cultured algal cells of known cell size with FP/cell rates of size fractionated (10-50µm) 
natural samples collected coastally around Monterey Bay.  According to the regression 
between cell volume and FP (Figure 41), a 10 µm cell has a predicted FP rate of 0.72 
pg/cell.hr, while a 50 µm cell has a predicted FP rate of 35 pg/cell.hr.  Each coastal 
Monterey Bay sample was measured by both Bulk FDA (collected on 10µm filters) and 
by flow cytometry for numeric concentration of live cells 10-50µm, enabling the 
calculation of per 10-50µm cell FP rates.  These rates were highly variable (coefficient of 
variation = 177%), ranging from 0.1-17 pg/cell.hr, with a mean of 2.6 pg/cell.hr and 
median of 1.2 pg/cell.hr.  All cells contributing to these counts are between 10-50µm, but 
the actual size of cells within this range is not known.  Variation in the dominant cell size 
among sample sites and days likely contributed towards the high variance observed in 
FP/cell rates.  Conversion of the coastal Monterey Bay FP/cell rates to an estimate of 
mean cell size yields a range of 5-39 µm (ESD) with a mean of 18 µm and a median of 
13 µm.  Estimates from both the mean and median fall within the 10-50 µm range, which 
is encouraging, as only cells between 10-50 µm are present in these size fractionated 
samples.  Both of these estimates are towards the lower end of the 10-50 µm range, 
which is in agreement with size distribution trends expected based on decades of research 
which shows that both the abundance and biomass of organisms in aquatic environments 
is inversely related to cell size (Cavender-Bares et al., 2001).  This suggests that the 
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relationship between cell volume and FP established using algal cultures is useful in 
predicting the live cell concentration of natural samples assayed by Bulk FDA.  
 Fluorescein Production and ATP     
The relationship between FP and ATP concentration was investigated in detail in 
this study using algal cultures, surface to deep water Monterey Bay samples and coastal 
Monterey Bay samples (Figure 39).  In all cases, FP and ATP are positively correlated, 
which confirms that the Bulk FDA technique measures viable biomass in the same 
manner as ATP.  However, the relationship between these indicators is not strictly 
proportional.  Log transformed regression of these two parameters (ATP on x-axis, FP on 
y-axis) using all coastal and offshore/deep Monterey Bay samples reveals that ATP varies 
over a greater range than FP, resulting in a slope of 0.67 (Figure 40a).  The same is true 
of the algal culture data (slope of log-log regression=0.85).  It is possible that a cause of 
this discrepancy is that too small a blank value is being used for Bulk FDA, resulting in 
higher than expected FP values in low biomass samples.  An empirical "blank" is 
subtracted from both the ATP and Bulk FDA values to correct for any non-biological 
signal.  For all ATP vs. FP comparisons, this blank consisted of FSW filtered and 
processed in the same way as samples.  It was observed that the discrepancy between the 
ranges spanned by FP and ATP could be corrected if a Bulk FDA blank value 3-times 
larger than the empirical blank was substituted; both viable biomass indicators then vary 
over approximately the same range, resulting in a slope approaching 1 on the log (FP) vs. 
log(ATP) regression (actual slope value =0.92) (Figure 40b).  However, no justification 
for using a larger Bulk FDA blank has been found.  Samples killed with high 
concentrations of bleach and processed for Bulk FDA show FP values similar to the FSW 
blank, suggesting that non-biological particles are not the cause of the high FP/ATP ratios 
observed in low biomass samples. 
It is also possible that the discrepancy between the range spanned by ATP and FP 
is not caused by low biomass samples, but rather samples in which high levels of biomass 
are loaded.  It has been shown that FP per unit cell volume decreases as cell volume 
increases, possibly due to inefficiency of exposing all cellular esterases to FDA in large 
cells.  In samples in which large amounts of biomass are collected on a filter, FDA may 
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not come in contact with cells hidden under a layer of material, resulting in lower FP than 
if all cells had been exposed.  The boiling extraction of ATP may be more efficient at 
capturing all ATP in these high biomass samples than the Bulk FDA technique is at 
exposing all esterases to FDA, resulting in ATP spanning a greater range than FP.        
 
Figure 38: Fluorescein production vs. ATP comparisons from 3 sources plotted 
together: water column profiles offshore in Monterey Bay, coastal Monterey Bay 
samples, and freshwater and marine algal cultures 
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Figure 39: a) The relationship between FP and ATP from Monterey Bay samples 
when the FP value is corrected by an empirical, cell-free blank b) The same 
relationship using FP values corrected by substituting a single value blank of 3x 
higher fluorescence than the empirical blank 
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CONCLUSION 
Optimization of the Bulk FDA technique has resulted in an assay that is greatly 
improved in terms of sensitivity, precision, accuracy and ease of use.  Moreover, 
knowledge obtained during the optimization process give the user the option of 
modifying aspects of the assay, such as pH, temperature, incubation time or volume, to 
suit their particular needs.  The optimized assay has adequate sensitivity to be used not 
only in natural environments, but also to evaluate sterilized water, such as treated ballast 
water, which contains little or no living organisms.  The relationships established by this 
thesis allow one to convert the bulk measure of living biomass generated by the Bulk 
FDA technique into a numeric estimate of living cell concentration.  The Bulk FDA assay 
is reliable, convenient, and can be carried out using portable instrumentation over a wide 
range in ambient temperatures by those with very little technical training.  This 
combination of features makes the Bulk FDA technique a unique tool and will promote 
its usefulness in a wide array of academic and regulatory applications.     
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